Trigger Alert: Jupiter Endovascular Series B
Jupiter Endovascular just closed Series B and is racing to finish SPIRARE II and prep commercial launch. Pitch trial management & launch services to CEO Carl St. Bernard—next touch awaits.
Published on
Do not index
Do not index
🚀 Battle Card: Jupiter Endovascular
Quick trigger:
This Jupiter Endovascular sales trigger puts them on the fast track for trial completion and commercial launch.
👤 Decision Maker in the News
- Carl St. Bernard, CEO 📧 <carl@jupiterendo.com>
💡 Why It Matters
- This Jupiter Endovascular sales trigger signals a shift from R&D to go-to-market acceleration. → Source
🎯 Core Pain Point
- Completing SPIRARE II pivotal clinical trial under time pressure
- Building commercialization infrastructure amid regulatory complexity
💰 What to Pitch
- Primary: Clinical trial management platform → Accelerate trial milestones and reporting
- Expansion: Commercial launch enablement services → Streamline market entry and partnerships
🗺️ Quick Context
- HQ: Menlo Park, CA
- Employees: ≈ 50
- Rev: ≈ $0.5 M (pre-commercial)
🤼 Competitive Intel
Which other vendors you’ll probably face to win Jupiter Endovascular’s business.
Sales
- Salesforce — CRM
- Unique edge: End-to-end sales analytics
- Evaluated by: VP Sales & CFO
- HubSpot — CRM & Sales Automation
- Unique edge: Integrated marketing & sales platform
- Evaluated by: Dir. Marketing & VP Ops
- Outreach — Sales Engagement
- Unique edge: AI-driven cadences
- Evaluated by: Sales Ops & AE teams
Marketing
- Marketo — Marketing Automation
- Unique edge: Robust lead nurturing
- Evaluated by: CMO & Dir. Marketing
- Mailchimp — Email Marketing
- Unique edge: User-friendly campaigns
- Evaluated by: Marketing Manager
- Pardot — B2B Marketing
- Unique edge: Salesforce integration
- Evaluated by: VP Marketing & IT
Product/Eng
- Atlassian Jira — Project Tracking
- Unique edge: Agile boards & reporting
- Evaluated by: CTO & Product Lead
- GitHub — Code Collaboration
- Unique edge: DevOps integrations
- Evaluated by: Dev Team & CTO
- Slack — Team Collaboration
- Unique edge: Channel-based comms
- Evaluated by: All Engineering Teams
✅ Do-Now Checklist
Connect with Carl St. Bernard on LinkedIn
Reference this Jupiter Endovascular sales trigger in your email subject line
Generate email + DM with the Copy-My-Prompt block and send first touch
Schedule follow-ups in CRM (Day 3 & Day 10)
Next Step
Get this Jupiter Endovascular sales trigger and more daily—no fluff, all pipeline.
Subscribe to NewsletterForLeads
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑❑
OFFER_BRIEF = ❑clinical trial management platform❑
PROOF_METRIC = ❑≈ TBD❑
CTA_STYLE = ❑quick_call❑
TONE = ❑friendly❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Carl
COMPANY = Jupiter Endovascular
DEPT = Executive
SIZE = 50
BOTTLENECK = Completing SPIRARE II pivotal clinical trial under time pressure
EVENT = Completes Series B Round
DETAIL = Series B financing oversubscribed, surpassed $40M
PAIN = Building commercialization infrastructure amid regulatory complexity
SRC = https://vcnewsdaily.com/jupiter-endovascular/venture-capital-funding/yywyrzhbvm
SIM_CO = ≈ TBD
WIN_METRIC = ≈ TBD
NEXT_SIZE = ≈ TBD
EMP_EST = ≈50
REV_EST = ≈$0.5M
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: 50-person Executive
Carl—noticed your Executive team is ≈ 50.
That’s when Completing SPIRARE II pivotal clinical trial under time pressure slows growth.
We helped ≈ TBD fix this with clinical trial management platform.
Result: ≈ TBD.
Quick call?
PS—next bottleneck hits ≈ TBD.
DM ≤45 words, TONE:
Saw your post about Series B financing oversubscribed, surpassed $40M — Building commercialization infrastructure amid regulatory complexity.
clinical trial management platform. ≈ TBD.
Quick chat?